Remdesivir
-
Hetero Healthcare Ltd starts supply of generic Remdesivir
Business | Jul 15, 2020, 12:53 PM ISTCovifor is the first generic brand of Remdesivir, which is meant for treatment of COVID-19 patients that are adults and children, hospitalised with severe symptoms of the disease.
-
Rumours on 'coronavirus vaccine' spread in Mumbai; crowds gather at Ghatkopar store
News | Jul 11, 2020, 09:20 PM ISTRumours spread in Mumbai on 'coronavirus vaccine'. Following this, people started gathering at a store in Ghatkopar.
-
Indiscriminate use of remdesivir, tocilizumab on COVID-19 patients can cause more harm than good
India | Jul 11, 2020, 08:38 PM ISTThe Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) have asked states to use drugs like remdesivir and tocilizumab, mentioned as investigational therapies, on COVID-19 patients strictly as per the laid down protocol as their "indiscriminate use or use in conditions for which they are not desirable may cause more harm than good".
-
Remdesivir linked to reduced death risk in severe COVID-19 patients
World | Jul 11, 2020, 04:26 PM ISTNew data revealed by Gilead Sciences has shown that its antiviral drug remdesivir reduces death risk of severe Covid-19 patients by as much as 62 per cent when compared with standard care alone.
-
Doctors advised to use Remdesivir on COVID-19 patients strictly under laid-down protocol
India | Jul 10, 2020, 09:29 PM ISTDoctors in state hospitals are being advised to use antiviral Remdesivir on COVID-19 patients strictly as per protocol amid some reports of liver damage in such patients treated with the drug, official sources said.
-
Shortage of coronavirus medicine Remdesivir in Delhi, Mumbai. What's the latest
India | Jul 10, 2020, 06:56 AM ISTSeveral cities across India, including Mumbai, Bangalore are reportedly facing a shortage of the experimental antiviral drug Remdesivir. Delhi is also struggling to source it from other cities or buying it at exorbitant prices. In Delhi, both private and government hospitals have reported depleting stock of the coronavirus medicine.
-
How Remdesivir can save lives in nations with lower hospital capacity
Science | Jul 08, 2020, 09:30 PM ISTAmid news that the US has bought up virtually the entire global supply of remdesivir, a new study outlines how the drug could save lives in countries with a lower hospital capacity, such as South Africa, where Covid-19 is beginning to overwhelm intensive care units (ICUs).
-
Cipla launches generic version of remdesivir in India
Business | Jul 08, 2020, 09:24 PM ISTPharma major Cipla on Wednesday said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowest globally and is looking to supply over 80,000 vials within the first month.
-
COVID-19: Mylan to launch remdesivir in India at Rs 4,800 per 100 mg vial
Business | Jul 07, 2020, 08:43 AM ISTThe company joins domestic pharma firm Cipla and Hetero who have already received permission from the Drug Controller General of India (DCGI) to manufacture and market remdesivir for the treatment of COVID-19.
-
US secures almost entire world stock of Covid-19 drug remdesivir
World | Jul 01, 2020, 06:25 PM ISTThe Donald Trump administration has secured nearly the entire world stock of antiviral drug remdesivir from US-based Gilead Sciences for the next three months, leaving hardly any stock of the key Covid-19 drug for the rest of the world.
-
Hetero set to deliver 20,000 vials of generic Remdesivir
Business | Jun 24, 2020, 04:16 PM ISTFollowing the approval of Covifor, the generic version of Remdesivir, by the Drug Controller General of India (DCGI), Hetero Healthcare Limited is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each.
-
Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial
Business | Jun 23, 2020, 09:03 PM ISTPharma major Cipla will price its generic version of antiviral drug remdesivir at less than Rs 5,000 per vial in keeping with its conviction of providing access to the medicines at affordable cost, the company said on Tuesday.
-
Remdesiver, Favipiravir antiviral drugs 'no game changers' in COVID-19 fight, say medical experts
India | Jun 22, 2020, 11:06 PM ISTWith pharmaceutical companies launching generic versions of Remdesivir and Favipiravir for COVID-19 treatment, medical experts on Monday said it was a "positive development" in the fight against the pandemic, but cautioned against regarding the antiviral drugs as "game changers".
-
Cipla launches generic remdesivir for COVID-19 patients
India | Jun 21, 2020, 11:28 PM ISTHomegrown pharma major Cipla Ltd announced the launch of its generic version of remdesivir, which has been authorised for emergency use in the treatment of COVID-19 patients by the USFDA, under its brand name Cipremi.
-
Hetero gets DCGI nod to launch COVID-19 drug
Business | Jun 21, 2020, 03:07 PM ISTDrug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19.
-
Health ministry recommends remdesivir for moderate cases, HCQ for early course of COVID-19
India | Jun 13, 2020, 07:28 PM ISTThe Health Ministry on Saturday recommended the use of antiviral drug remdesivir in a moderate stage of COVID-19 while backtracking from its earlier stance on hydroxychloroquine, saying the anti-malarial drug should be used in the early course of the disease and not on critically ill patients.
-
Dr Reddy's inks pact with Gilead Sciences for Remdesivir
India | Jun 13, 2020, 04:38 PM ISTDr. Reddy's Laboratories Ltd on Saturday announced it has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. that will grant the city-based drug maker right to register, manufacture and sell Gilead's investigational drug, Remdesivir
-
Zydus Cadila inks licensing pact with Gilead for remdesivir
Business | Jun 12, 2020, 09:16 PM ISTDrug firm Zydus Cadila on Friday said it has signed a non-exclusive licensing agreement with Gilead Sciences Inc for manufacturing and distribution of remdesivir, a potential therapy for COVID-19.
-
Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients
India | Jun 11, 2020, 04:46 PM ISTAnti-viral drug remdesivir and tocilizumab, an immunomodulator, are being considered for "restricted use" on severely ill COVID-19 patients on "emergency and compassionate grounds", according to revised clinical management guidelines to be released soon.
-
Remdesivir improves time to recovery in COVID-19 patients: Study
Science | May 27, 2020, 11:18 AM ISTRemdesivir, the antiviral under clinical trials for treatment against novel coronavirus infection, is superior to the standard of care given to COVID-19 patients, according to a new study.